Biology of bone tissue: structure, function, and factors that influence bone cells

R Florencio-Silva, GRS Sasso… - BioMed research …, 2015 - Wiley Online Library
Bone tissue is continuously remodeled through the concerted actions of bone cells, which
include bone resorption by osteoclasts and bone formation by osteoblasts, whereas …

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

RT Gansevoort, R Correa-Rotter, BR Hemmelgarn… - The Lancet, 2013 - thelancet.com
Since the first description of the association between chronic kidney disease and heart
disease, many epidemiological studies have confirmed and extended this finding. As …

Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials

M Wolf, J Rubin, M Achebe, MJ Econs, M Peacock… - Jama, 2020 - jamanetwork.com
Importance Intravenous iron enables rapid correction of iron-deficiency anemia, but certain
formulations induce fibroblast growth factor 23–mediated hypophosphatemia. Objective To …

Hypoparathyroidism

M Mannstadt, JP Bilezikian, RV Thakker… - Nature Reviews …, 2017 - nature.com
Hypoparathyroidism is a disease characterized by inadequately low circulating
concentrations of parathyroid hormone (PTH) resulting in low calcium levels and increased …

Osteoblast and osteocyte: games without frontiers

M Capulli, R Paone, N Rucci - Archives of biochemistry and biophysics, 2014 - Elsevier
The portrait of osteoblasts and osteocytes has been subjected to a revision, since a large
body of evidence is attributing these cells amazing roles both inside and outside the bone …

[HTML][HTML] Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

S Singh, A Grabner, C Yanucil, K Schramm, B Czaya… - Kidney international, 2016 - Elsevier
Patients with chronic kidney disease (CKD) develop increased levels of the phosphate-
regulating hormone, fibroblast growth factor (FGF) 23, that are associated with a higher risk …

FGF23 and klotho at the intersection of kidney and cardiovascular disease

D Edmonston, A Grabner, M Wolf - Nature Reviews Cardiology, 2024 - nature.com
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease
(CKD). As CKD progresses, CKD-specific risk factors, such as disordered mineral …

[HTML][HTML] PTH and vitamin D

SJ Khundmiri, RD Murray, E Lederer - Comprehensive Physiology, 2016 - ncbi.nlm.nih.gov
PTH and Vitamin D are two major regulators of mineral metabolism. They play critical roles
in the maintenance of calcium and phosphate homeostasis as well as the development and …

[HTML][HTML] Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

JP Law, L Pickup, D Pavlovic, JN Townend… - Journal of Human …, 2023 - nature.com
Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15%
worldwide. An inverse-graded relationship exists between cardiovascular events and …

Regulation and function of the FGF23/klotho endocrine pathways

A Martin, V David, LD Quarles - Physiological reviews, 2012 - journals.physiology.org
Calcium (Ca2+) and phosphate (PO43−) homeostasis are coordinated by systemic and local
factors that regulate intestinal absorption, influx and efflux from bone, and kidney excretion …